1-9 of 9
Jacqueline Garcia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognosis in adults with ph-positive B-ALL in first complete remission without minimal residual disease after blinatumomab consolidation is influenced by minimal residual disease (≥10-4) pre-blinatumomab

Free
Benjamin Frost, Yannis Valtis, Yael Flamand, Emilie Baxter, David Nemirovsky, Andriy Derkach, Kuo-Kai Chin, Meira Yisraeli Salman, Leora Boussi, Natalia Tijaro Ovalle, Eytan Stein, Mark Geyer, Shai Shimony, Jacqueline Garcia, Martha Wadleigh, Eric Winer, Virginia Volpe, Maximilian Stahl, Richard Stone, Daniel Deangelo, Jae Park, Marlise Luskin, Evan Chen
Journal: Blood
Blood (2025) 146 (Supplement 1): 3329.
https://doi.org/10.1182/blood-2025-3329
Published: 2025
Journal Articles

Ven+FluBu2 with ptcy/tac/MMF RIC transplant followed by venetoclax/azacitidine maintenance for high-risk MDS/AML

Free
H. Moses Murdock, Kyle Hebert, Jennifer Brock, Elise Auriemma, Felicia Lim, Jeremy Ryan, Mahasweta Gooptu, Roman Shapiro, Corey Cutler, Amar Kelkar, Vincent Ho, Denbaa Bat-Erdene, Anthony Letai, Jerome Ritz, R. Coleman Lindsley, Joseph Antin, Robert Soiffer, Jacqueline Garcia
Journal: Blood
Blood (2025) 146 (Supplement 1): 4206.
https://doi.org/10.1182/blood-2025-4206
Published: 2025
Journal Articles

Temporal multiomic profiling reveals intrinsic resistance mechanisms to ERK inhibition in relapsed Acute Myeloid Leukemia

Free
Rahul Vedula, Hannah Karp, Danielle Morrow, Andrew Gehrke, Yiwen Liu, Ellen Weisberg, Carter Lombardi, Rebecca Leonard, Ilene Galinsky, Jacqueline Garcia, Marlise Luskin, Maximilian Stahl, Martha Wadleigh, Eric Winer, Daniel Deangelo, James Griffin, Richard Stone, R. Coleman Lindsley
Journal: Blood
Blood (2025) 146 (Supplement 1): 3265.
https://doi.org/10.1182/blood-2025-3265
Published: 2025
Journal Articles

Tagraxofusp, azacitidine, and venetoclax (TAG-AZA-VEN) triplet therapy shows efficacy, tolerability, and transplant potential in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): Results of a phase 2 trial

Free
Andrew Lane, Marlise Luskin, Julia Keating, Nicole Leboeuf, Jacqueline Garcia, Shai Shimony, Rebecca Leonard, Adon Goodpaster, Theresa Nguyen, Ilene Galinsky, Ashleigh Eberly-Puleo, Naval Daver, Nitin Jain, Guillermo Garcia-Manero, Hagop Kantarjian, Marina Konopleva, Anthony Selwyn Stein, Naveen Pemmaraju
Journal: Blood
Blood (2025) 146 (Supplement 1): 653.
https://doi.org/10.1182/blood-2025-653
Published: 2025
Journal Articles

Venetoclax plus inotuzumab ozogamicin for relapsed and refractory ALL: Results of a phase I trial

Free
Marlise Luskin, Julia Keating, Benjamin Frost, Yael Flamand, Jacqueline Garcia, Richard Stone, Rebecca Leonard, Stella Jaeckle, Chase Weizer, Jessica Lee, Ilene Galinsky, Jeremy Ryan, Eric Winer, Evan Chen, Anthony Letai, Mark Murakami, Daniel Deangelo
Journal: Blood
Blood (2025) 146 (Supplement 1): 645.
https://doi.org/10.1182/blood-2025-645
Published: 2025
Journal Articles

Mechanisms of immune escape and altered tissue homing in leukemia cutis

Free
Livius Penter, Alexandria Maurer, Nicoletta Cieri, Wesley Lu, Haoxiang Lyu, Shuqiang Li, Kenneth Livak, Lars Bullinger, Jerome Ritz, Pavan Bachireddy, Matthew S Davids, Jacqueline Garcia, Robert Soiffer, Catherine Wu
Journal: Blood
Blood (2025) 146 (Supplement 1): 2483.
https://doi.org/10.1182/blood-2025-2483
Published: 2025
Journal Articles

Retrospective real-world analysis of ropeginterferon ALFA-2B use in patients with polycythemia vera and essential thrombocythemia: Practice patterns, tolerance, and outcomes

Free
Katherine Feder, Jessica Freydman, Yue Ren, Shruti Gajjar, Victor You, David Sirignano, Svitlana Tyekucheva, Andrew Brunner, Jean M. Connors, Daniel Deangelo, Amir Fathi, Jacqueline Garcia, Chi-Joan How, Marlise Luskin, Richard Stone, Virginia Volpe, Michelle Lee, Gabriela Hobbs
Journal: Blood
Blood (2025) 146 (Supplement 1): 7338.
https://doi.org/10.1182/blood-2025-7338
Published: 2025
Journal Articles

Subgroup analyses from the randomized, Phase 3 VERONA study of venetoclax with azacitidine (Ven+Aza) versus placebo with azacitidine (Pbo+Aza) in patients with treatment-naïve, intermediate and higher-risk Myelodysplastic Syndromes (HR MDS)

Free
Guillermo Garcia-Manero, Uwe Platzbecker, Pierre Fenaux, Gail Roboz, Chun Yew Fong, Marek Hus, Robert Delage, Andrew Brunner, Je-Hwan Lee, Mehmet Turgut, Dominiek Mazure, Yin-Hsun Feng, Yasushi Miyazaki, Zdeněk Kořístek, Sophie Salazar, Stefania Paolini, Maria Diez-Campelo, David Lavie, Dominic Culligan, Grace Ku, Zhijian Xiao, Fang Fang, Maggie Headley, Jalaja Potluri, Amer Zeidan, Jacqueline Garcia
Journal: Blood
Blood (2025) 146 (Supplement 1): 235.
https://doi.org/10.1182/blood-2025-235
Published: 2025
Journal Articles

Early TCR diversity and recipient stem-cell persistence predict relapse and reveal therapeutic targets after allogeneic transplantation

Free
Nurefsan Sariipek, Ksenia Safina, Shuqiang Li, Wesley Lu, J Thomas Janes, McKayla Van Orden, Haynes Heaton, Corey Cutler, Vincent Ho, John Koreth, R. Coleman Lindsley, Marlise Luskin, Jacqueline Garcia, Kenneth Livak, Gabriel Griffin, Robert Soiffer, Jerome Ritz, Catherine Wu, Joseph Antin, Andrew Lane, Mahasweta Gooptu, Peter van Galen
Journal: Blood
Blood (2025) 146 (Supplement 1): 6065.
https://doi.org/10.1182/blood-2025-6065
Published: 2025